Analysis Omni Health Inc (OMHE)
6/3/2024
Analysis of Omni Health Inc (OMHE)
Omni Health Inc (OMHE) is currently trading at a price of 0.00002. The Relative Strength Index (RSI) indicator is quite high at 93.51, indicating that the stock may be overbought. The Moving Average Convergence Divergence (MACD) indicator is at 0.00000, with the MACD line crossing above the signal line.Looking at the historical data, the stock has been trading at around 0.00001 in the past few days. The RSI indicator has been consistently low at 0.00487, suggesting a lack of strong momentum in the stock.
Overall, based on the current RSI and MACD indicators, it seems that Omni Health Inc may be overbought in the short term. Traders and investors may want to exercise caution and wait for a potential pullback before considering any entry positions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows volatility within a fifty-two week range and provides moving averages for 50 and 200 days.
Valuation metrics reveal a high PEG ratio and price-to-earnings ratios, along with other valuation multiples. The market capitalization and enterprise value are also provided.
Lastly, dividends and splits information includes details on dividend rates, yields, payout ratios, and historical split data for the company.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The gross profit margin seems to be consistent, indicating efficient cost management.
3. Earnings before interest and taxes (EBIT) have also shown a positive trend, reflecting the company's operational efficiency.
4. Net income has been growing, suggesting that the company is effectively managing its expenses and taxes.
5. The basic and diluted earnings per share (EPS) have been relatively stable over the years.
6. The company has been able to maintain a healthy operating income despite fluctuations in other income and expenses.
7. The number of basic and diluted shares outstanding has remained constant, indicating no significant dilution of shares.
8. Overall, the financial performance of the company, as indicated by its revenues, seems to be on a positive trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, peaking at $234,386,000,000 in 2018.
4. Total liabilities have also been on the rise, with the highest value in 2018 at $255,355,000,000.
5. Shareholders' equity has generally increased, with the highest value in 2018 at $107,147,000,000.
6. The company has been investing more in non-current assets over the years, indicating potential long-term growth strategies.
7. There seems to be a consistent focus on maintaining a healthy balance between assets and liabilities to ensure sustainable growth.
Cash Flow 💶
This is the cash flow statement. Here are some key takeaways from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
4. Investing activities reflect significant amounts spent on the sale and purchase of investments, with fluctuations in capital expenditures.
5. The end cash position has varied over the years, reaching its peak in 2020.
6. Interest paid and income tax paid have also shown fluctuations, impacting the company's overall cash flow position.
These insights provide a snapshot of the company's financial health and its management of cash flow over the past few years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 from the same quarter last year.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth from the EPS of $5.67 for the previous year.
4. Looking ahead to the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This is an increase from the EPS of $6.10 for the current year.
Overall, the analysts are forecasting growth in earnings per share for both the upcoming quarters and the next fiscal year.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts providing estimates remains at 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates increases to 38.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates remains at 38.
Overall, the analysts are forecasting moderate to strong sales growth for both the upcoming quarters and the next fiscal year, with an increasing number of analysts providing estimates for the company's performance.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. The current year growth rate is estimated to be 7.6%.
2. The next quarter growth rate is expected to be 5.1%.
3. The current quarter growth rate is also estimated at 5.1%.
4. The next year growth rate is projected to be 9.7%.
5. Over the next 5 years, the company's growth rate is anticipated to be around 9.7% per annum.
6. However, over the past 5 years, the company has experienced a higher growth rate of approximately 20.1% per annum.
These estimates suggest that the company is expected to maintain a steady growth rate in the upcoming periods, with a slightly higher growth rate projected for the next year compared to the current year. Additionally, the past 5 years have seen a significantly higher growth rate, indicating a period of strong performance for the company.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average forecast at $204.58. The current price of the security is $192.25, which is below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making decisions about buying or selling the security.
MACD of OMHE
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
